To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 26,344 shares, the number of shares held increased 0.25% compared to the previous period and now represents 0.96% of the total position.
      5.14K1
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Prime Medicine, Inc. by 18,620 shares, the number of shares held increased 0.25% compared to the previous period and now represents 1.34% of the total position.
      82Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Generate Biomedicines by 3,066 shares, the number of shares held increased 0.25% compared to the previous period and now represents 1.13% of the total position.
      54Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Butterfly Network Inc by 11,822 shares, the number of shares held increased 0.25% compared to the previous period and now represents 2.49% of the total position.
      98Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Alamar Biosciences by 2,372 shares, the number of shares held increased 0.25% compared to the previous period and now represents 1.65% of the total position.
      75Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Nurix Therapeutics by 4,168 shares, the number of shares held increased 0.25% compared to the previous period and now represents 2.48% of the total position.
      14Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in GeneDx Holdings by 1,106 shares, the number of shares held increased 0.25% compared to the previous period and now represents 1.93% of the total position.
      8Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Schrodinger Inc. by 5,062 shares, the number of shares held increased 0.25% compared to the previous period and now represents 1.98% of the total position.
      2Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Ionis Pharmaceuticals by 1,316 shares, the number of shares held increased 0.25% compared to the previous period and now represents 1.84% of the total position.
      114Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 33,800 shares, the number of shares held increased 0.25% compared to the previous period and now represents 2.76% of the total position.
      392Comment
      Report
       
       
       
       

      Most Discussed